Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome

Background: Growth arrest-specific factor 6 (GAS6) and the Tyro3, AXL, and MERTK (TAM) receptors counterbalance pro-inflammatory responses. AXL is a candidate receptor for SARS-CoV-2, particularly in the respiratory system, and the GAS6/AXL axis is targeted in current clinical trials against COVID-1...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Biomedicines
Autores principales: Morales, Albert, Rojo Rello, Silvia, Cristóbal, Helena, Fiz-López, Aida, Arribas, Elisa, Marí, Montserrat, Tutusaus, Anna, de la Cal-Sabater, Paloma, Nicolaes, Gerry A.F., Ortiz-Pérez, José T., Bernardo, David, García de Frutos, Pablo
Formato: Artigo
Lenguaje:Inglês
Publicado: MDPI 2021
Materias:
Communication
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC8065652/
https://ncbi.nlm.nih.gov/pubmed/33810394
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biomedicines9040335
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares